相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Alison E. Mahan et al.
PLOS PATHOGENS (2016)
Obinutuzumab for relapsed or refractory indolent non-Hodgkin's lymphomas
Ludovic Gabellier et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome
Irena Trbojevic Akmacic et al.
INFLAMMATORY BOWEL DISEASES (2015)
The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development
Lowell J. Brady et al.
MABS (2015)
Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding
Jinghua Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Structural Role of Antibody N-Glycosylation in Receptor Interactions
Ganesh P. Subedi et al.
STRUCTURE (2015)
FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities
Falk Nimmerjahn et al.
TRENDS IN IMMUNOLOGY (2015)
High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
Ganesh P. Subedi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Three major uncertainties in the antibody therapy of cancer
George T. Stevenson
HAEMATOLOGICA (2014)
Immunoglobulin G1 Fc Domain Motions: Implications for Fc Engineering
Martin Frank et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Fc Gamma Receptor Glycosylation Modulates the Binding of IgG Glycoforms: A Requirement for Stable Antibody Interactions
Jerrard M. Hayes et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity
Stefanie Derer et al.
MABS (2014)
Restricted Motion of the Conserved Immunoglobulin G1 N-Glycan Is Essential for Efficient FcγRIIIa Binding
Ganesh P. Subedi et al.
STRUCTURE (2014)
Changes in IgG and total plasma protein glycomes in acute systemic inflammation
Mislav Novokmet et al.
SCIENTIFIC REPORTS (2014)
Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
Josee Golay et al.
BLOOD (2013)
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
James D. Mellor et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs
Anja Lux et al.
JOURNAL OF IMMUNOLOGY (2013)
High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides
Maja Pucic Bakovic et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Engineering Hydrophobic Protein-Carbohydrate Interactions to Fine-Tune Monoclonal Antibodies
Xiaojie Yu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy
Max Crispin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Development of orally active inhibitors of protein and cellular fucosylation
Nicole M. Okeley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers
Gordan Lauc et al.
PLOS GENETICS (2013)
NMR Characterization of Immunoglobulin G Fc Glycan Motion on Enzymatic Sialylation
Adam W. Barb et al.
BIOCHEMISTRY (2012)
Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone
Daniel O. Persky et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Anti-inflammatory IgG Production Requires Functional P1 Promoter in β-Galactoside α2,6-Sialyltransferase 1 (ST6Gal-1) Gene
Mark B. Jones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
Cory D. Rillahan et al.
NATURE CHEMICAL BIOLOGY (2012)
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Tsunehiro Mizushima et al.
GENES TO CELLS (2011)
Functional Characteristics of the High Affinity IgG Receptor, FcγRI
Cees E. van der Poel et al.
JOURNAL OF IMMUNOLOGY (2011)
NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic
Adam W. Barb et al.
NATURE CHEMICAL BIOLOGY (2011)
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose
Claudia Ferrara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A global benchmark study using affinity-based biosensors
Rebecca L. Rich et al.
ANALYTICAL BIOCHEMISTRY (2009)
Branch-Specific Sialylation of IgG-Fc Glycans by ST6Gal-I
Adam W. Barb et al.
BIOCHEMISTRY (2009)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation
Mami Shibata-Koyama et al.
GLYCOBIOLOGY (2009)
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc
Robert M. Anthony et al.
SCIENCE (2008)
FCGR2A and FCGR3A Polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab
Wu Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
W. Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types
Yutaka Kanda et al.
GLYCOBIOLOGY (2007)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy
Y Yamaguchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
The carbohydrate at FcγRIIIa Asn-162 -: an element required for high affinity binding to non-fucosylated IgG glycoforms
C Ferrara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa
A Okazaki et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Rituximab-dependent cytotoxicity by natural killer cells:: Influence of FCGR3A polymorphism on the concentration-effect relationship
S Dall'Ozzo et al.
CANCER RESEARCH (2004)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding
Y Mimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex
P Sondermann et al.
NATURE (2000)
分享论文
